复合干扰素联合利巴韦林治疗难治性慢性丙型肝炎74例疗效分析

目的 探讨复合干扰素(comb interferon,CITF)联合利巴韦林治疗复发及无应答慢性丙型肝炎的效果.方法 对74例干扰素治疗后复发或无应答的慢性丙型肝炎患者,用复合干扰素15 μg,每周3次,皮下注射,疗程24周,观察治疗过程中、治疗结束时及停药半年后的临床症状、体征、ALT、丙型肝炎病毒持续免疫应答率及不良反应情况.结果 72例患者完成治疗,复发组和无应答组治疗结束后HCV.RNA持续阴转率分别为73%和37%(P＜0.05),未发现严重不良反应.结论 复合干扰素联合利巴韦林用于治疗复发或无应答的慢性丙型肝炎有一定的疗效.

Clinical analysis of comb interferon curing 74 patients with chronic hepatitis C

Objective To investigate the effect of comb interferon( comb interferon CITF) uniting virazole to cure recurring or non-responding chronic hepatitis C.Methods Hypodermic comb "interferon 15μg,3 times every week,subcutaneously injected,24 weeks course of treatment was adminstered to 74 patients of recurring or non-responding chronic hepatitis C.Clinical symptom,physical sign,ALT,hepatovirus continual response rate and the condition of adverse effect were observed during treatment,chron-culminate,follow to 6 months' withdrawl.Results 72 patients accomplished treatment,HCV-RNA of recurring group and non-responding group to continual negative change rate were 73% and 37% (P＜0.05)after treatment termination,without severity adverse reaction being found.Condusion Comb interferon 15 μg/d combining virazole 900mg/d have better curative effect in curing recurring or nonresponding chronic hepatitis C.